// App-Quantinova.ai

: Characteristics and treatment regimens across ERS SHARP severe asthma registries

Researchers

Presenter

  • Job J.M.H. van Bragt

Principal Investigators

  • Gary Anderson

  • Elisabeth H.D. Bel

  • Gert-Jan Braunstahl

  • Anneke Ten Brinke

  • John Busby

  • Giorgio W. Canonica

  • Hui Cao

  • Kian Fan Chung

  • Zsuzsanna Csoma

  • Donna E. Davies

  • Barbro Dahlen

  • Ratko Djukanovic

  • Cline Genton

  • Toni Gibson-Latimer

  • Dominique Hamerlijnck

  • Liam Heaney

  • Elise Heuvelin

  • Ildiko Horvath

  • Stephanie Korn

  • Maxim Kots

  • Piotr Kuna

  • Namhee Kwon

  • Renaud Louis

  • Riad Naddaf

  • Vicente Plaza

  • David Ramos Barbon

  • Levi B. Richards

  • Sabina Skrgat

  • Els J.M. Weersink

  • Valentyna Yasinska

  • Scott S. Wagers

  • Anke H. Maitland-Van Der Zee

Medical Centers

  • Amsterdam UMC, University of Amsterdam, Department of Internal and Vascular Medicine, Amsterdam, Netherlands

  • National Heart and Lung Institute, Imperial College London, London, United Kingdom

  • Orygen Youth Health Research Centre, University of Melbourne, Melbourne, Australia

  • Franciscus Gasthuis & Vllietland, Rotterdam, Netherlands

  • Medical Center Leeuwarden, Leeuwarden, Netherlands

  • Centre for Experimental Medicine, School of Medicine, Dentistry & Biomedical Science, Queens University Belfast, Northern Ireland, UK

  • Personalized Medicine Clinic, Asthma and Allergy, Humanitas Clinical and Research Center, Humanitas University, Rozzano and SANI-Severe Asthma Network Italy, Milan, Italy

  • Novartis Pharmaceuticals Corporation East Hanover NJ United States

  • National Heart and Lung Institute, Imperial College London, London, United Kingdom

  • National Koranyi Institute of TB and Pulmonology, Budapest, Hungary.

  • Institute for Health Research, Southampton Respiratory Biomedical Research Unit and Clinical Experimental Sciences, University of Southampton, Southampton, United Kingdom

  • Division of Respiratory Medicine and Allergy, Department of Medicine, Karolinska University Hospital, Huddinge, Sweden

  • European Respiratory Society, Lausanne, Switzerland

  • European Lung Foundation, Sheffield, United Kingdom

  • Universitatsmedizin, Mainz, Germany

  • Chiesi Farmaceutici, Global Clinical Development, Parma, Italy

  • Department of Internal Medicine, Asthma and Allergy, Medical University of Lodz, Lodz, Poland,

  • Respiratory Medical Franchise, GSK, London, United Kingdom.

  • Department of Pulmonary Medicine, Centre Hospitalier Universitaire (CHU), Liege University, Liege, Belgium

  • Teva Pharmaceuticals, Amsterdam, Netherlands,

  • Hospital de la Santa Creu Sant Pau, Universidad Autonoma de Barcelona, Barcelona, Spain

  • BioSciConsulting, Maasmechelen, Belgium,

Locations

  • Netherlands

  • United Kingdom

  • Australia

  • Italy

  • United States

  • Hungary

  • Sweden

  • Switzerland

  • Germany

  • Poland

  • Belgium

  • Spain

  • Slovenia

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cross-Sectional

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved